David Matthew Kratochvil, Chief Financial Officer at VOLITIONRX LTD (VNRX), bought 10,000 shares at $5.00 ($50K) on 2016-10-05, disclosed to the SEC on 2016-10-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.